延伸閱讀
- Chang, Y. Y. (2015). 三陰性乳癌分子生物特徵研究與探討 [doctoral dissertation, National Taiwan University]. Airiti Library. https://doi.org/10.6342/NTU.2015.02600
- 蕭雅嘉（2021）。合成KIF2C抑制劑用於三陰性乳癌治療之構效關係研究〔碩士論文，國立清華大學〕。華藝線上圖書館。https://www.airitilibrary.com/Article/Detail?DocID=U0016-0203202211542074
- 張耀仁（2023）。抗體複合藥物治療乳癌第四期患者成效佳。健康世界，(555)，52-54。https://www.airitilibrary.com/Article/Detail?DocID=16077059-N202303240003-00020
- Chen, J. Y. (2014). Deoxyelephantopin衍生物抑制人類三陰性乳腺癌之研究 [master's thesis, Taipei Medical University]. Airiti Library. https://www.airitilibrary.com/Article/Detail?DocID=U0007-2907201417111300
- Wu, J. J. (2021). 多巴胺衍生的碳化聚合物點對三陰性乳腺癌進行抗癌與抗轉移治療 [master's thesis, National Tsing Hua University]. Airiti Library. https://www.airitilibrary.com/Article/Detail?DocID=U0016-2412202116194662